Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field.
Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.
- Does not allow reviews to be publicly displayed
- Only allows reviewers to display the journal they reviewed for
- Does not allow reviewers to sign or publicly display reviews of rejected publications subsequently published in another journal
Interested in reviewing for this journal?
Editorial board members on Publons
Publons users have indicated that they sit on Pharmacogenomics' editorial board but we are unable to verify these claims.
Top reviewers on Publons (Manuscripts reviewed in last 12 months)
No one has yet endorsed Pharmacogenomics.
Review contents for Pharmacogenomics are not publicly displayed on Publons, in accordance with their editorial policy.